Profile data is unavailable for this security.
About the company
Hua Medicine is a China-based company principally engaged in the drug development business. The Company is mainly engaged in the development of an oral drug, Dorzagliatin, or HMS5552, for the treatment of Type 2 diabetes. The Company mainly operates its business in the domestic and overseas markets.
- Revenue in HKD (TTM)82.62m
- Net income in HKD-227.79m
- Incorporated2009
- Employees177.00
- LocationHua MedicineHua Medicine, 275 Ai Di Sheng RoadSHANGHAI 201203ChinaCHN
- Phone+86 2 158869997
- Websitehttps://www.huamedicine.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hbm Holdings Ltd | 698.94m | 178.03m | 1.15bn | 177.00 | 6.19 | 1.18 | 5.39 | 1.65 | 0.2422 | 0.2422 | 0.9523 | 1.28 | 0.3886 | 3.90 | 3.01 | 3,948,808.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.18bn | 1.59k | 5.30 | 0.4947 | 2.98 | 0.7012 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
| Ascletis Pharma Inc | 61.03m | -156.06m | 1.28bn | 219.00 | -- | 0.5202 | -- | 20.91 | -0.1467 | -0.1467 | 0.0568 | 2.42 | 0.022 | 2.30 | 3.86 | 278,688.90 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
| VIVA Biotech Holdings | 2.32bn | -125.22m | 1.36bn | 2.08k | -- | 0.3393 | 11.33 | 0.5858 | -0.0637 | -0.0637 | 1.20 | 1.86 | 0.2805 | 4.84 | 5.21 | 1,119,194.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 1.00 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
| Mabpharm Ltd | 93.99m | -225.77m | 1.42bn | 347.00 | -- | 6.43 | -- | 15.14 | -0.0548 | -0.0548 | 0.0228 | 0.0536 | 0.0893 | 0.1176 | 6.02 | 270,876.10 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.42bn | 1.48k | 5.35 | 0.7405 | 4.26 | 0.8347 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Wuhan YZY Biopharma Co Ltd | -100.00bn | -100.00bn | 1.44bn | 123.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1.50 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 68.50m | -387.27m | 1.50bn | 301.00 | -- | 1.30 | -- | 21.96 | -0.501 | -0.501 | 0.0886 | 1.46 | 0.0419 | -- | 5.21 | 227,573.70 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| TOT Biopharm International Co Ltd | 841.83m | -40.72m | 1.52bn | 551.00 | -- | 2.06 | 289.76 | 1.81 | -0.0562 | -0.0562 | 1.16 | 0.9582 | 0.5808 | 1.87 | 8.03 | 1,527,816.00 | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| Immunotech Biopharm Ltd | 0.00 | -361.07m | 1.57bn | 211.00 | -- | 8.41 | -- | -- | -0.7017 | -0.7017 | 0.00 | 0.3638 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -2.51 | 0.4327 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
| Cryofocus Medtech Shanghai Co Ltd | 44.16m | -105.13m | 1.63bn | 392.00 | -- | 9.34 | -- | 36.82 | -0.4397 | -0.4397 | 0.1847 | 0.7282 | -- | -- | -- | 112,653.80 | -- | -- | -- | -- | 75.83 | -- | -258.23 | -- | 4.08 | -- | 0.0597 | -- | 50.83 | -- | 13.13 | -- | -- | -- |
| Hua Medicine | 82.62m | -227.79m | 1.65bn | 177.00 | -- | 14.02 | -- | 19.93 | -0.233 | -0.233 | 0.0846 | 0.1113 | 0.0538 | 1.69 | 13.03 | 466,756.30 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
| CStone Pharmaceuticals | 500.21m | -396.02m | 1.67bn | 230.00 | -- | 3.39 | -- | 3.34 | -0.314 | -0.314 | 0.396 | 0.3836 | 0.2811 | 2.44 | 3.72 | 2,174,805.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.24bn | 351.56m | 1.79bn | 1.14k | 5.09 | 0.5799 | 3.95 | 1.44 | 0.2339 | 0.2339 | 0.8262 | 2.05 | 0.3156 | 2.31 | 6.37 | 1,086,080.00 | 8.85 | 9.89 | 11.36 | 12.49 | 54.60 | 56.69 | 28.03 | 27.89 | 2.26 | 28.89 | 0.0405 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
| SinoMab Bioscience Ltd | 1.47m | -262.17m | 2.11bn | 215.00 | -- | 6.27 | -- | 1,431.44 | -0.2575 | -0.2575 | 0.0015 | 0.308 | 0.0015 | -- | -- | 6,846.56 | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -11.48 | 0.604 | -- | -- | -- | 14.45 | -- | 106.81 | -- |
| Acotec Scientific Holdings Ltd | 511.00m | 15.62m | 2.11bn | 638.00 | 129.53 | 1.51 | 32.20 | 4.13 | 0.052 | 0.052 | 1.70 | 4.46 | 0.3136 | 0.7213 | 3.44 | 800,933.40 | 0.9589 | -- | 1.03 | -- | 79.65 | -- | 3.06 | -- | 9.12 | 2.75 | 0.1529 | -- | 19.80 | -- | -79.35 | -- | -- | -- |
Data as of May 24 2024. Currency figures normalised to Hua Medicine's reporting currency: Hong Kong Dollar HKD
5.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 30 Apr 2024 | 25.00m | 2.37% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 14.26m | 1.35% |
| Allspring Global Investments LLCas of 28 Mar 2024 | 9.38m | 0.89% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 5.88m | 0.56% |
| CRUX Asset Management Ltd.as of 31 Mar 2023 | 4.07m | 0.39% |
| State Board of Administration of Florida Retirement Systemas of 30 Jun 2023 | 2.32m | 0.22% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 560.00k | 0.05% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 180.00k | 0.02% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 160.40k | 0.02% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
